Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 6 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
5(100.0%)
5Total
Phase 2(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05158647Phase 2Completed

Adding Magnesium Sulfate to Bupivacaine for Ilioinguinal and Iliohypogastric Nerve Block

Role: lead

NCT04608006Completed

Epidural Analgesia and Delivery of Second Twin

Role: lead

NCT02724605Phase 2Completed

The Effect of Red Blood Cells Storage Duration on Biochemical Changes in Pediatric Patients

Role: lead

NCT02716129Phase 2Completed

The Effect of Adding Nalbuphine to Intrathecal Morphine on Analgesic Efficacy and Side Effects After Cesarean Section

Role: lead

NCT02723487Phase 2Completed

Ultrasound Guided Transversus Abdominis Plane Block in Pediatric Surgery

Role: lead

NCT03030560Phase 2Completed

Longterm Postoperative Analgesia, Intravenous Lidocaine Infusion

Role: lead

All 6 trials loaded